We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Reveals that soluble epoxide hydrolase inhibition reduces inflammation and myocardial injury in arrhythmogenic cardiomyopathy, highlighting lipid autocoids as therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Panigrahy et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: